Policy Comments

The priority legislative and regulatory issues that the Cancer Policy Institute focuses on are driven by policy pillars that are centered around the values, needs, and preferences of individuals impacted by cancer. We work in conjunction with patients, patient advocacy organizations, medical associations, and other stakeholders to advance policies aimed at improving access to, affordability of, and quality of care across the cancer continuum.

    CSC Letter To HELP Committee Re: The PREVENT Pandemics Act Discussion Draft (February 2022)
    Paid Leave, COVID-19, Telehealth, Public Health, Clinical Trials
    Group Letter To CMS CCIIO Urging The Rejection Of The Two Stage Weighted Model Specification In The Draft 2023 Notice Of Benefit And Payment Parameters (February 2022)

     

     

    Access to Affordable, Comprehensive Care, Affordable Care Act, Medicare, Medicaid, and Private Health Insurance Coverage, Anti-discrimination
    Group Letter To HELP Committee Re: Modernizing Clinical Trials In The PREVENT Pandemics Act Discussion Draft (February 2022)
    Telehealth, COVID-19, Clinical Trials
    Group Letter To HHS Re: Concerns About The Proposed National Coverage Determination On Anti Amyloid Monoclonal Antibodies (February 2022)
    Medicare, Medicaid, and Private Health Insurance Coverage, FDA, Cancer Research
    Group Letter To Senate And House Leadership On Cancer Moonshot And ARPA H (February 2022)
    Cancer Research, Clinical Trials, Health Equity
    OVAC Letter To Congress Urging The Passage Of A FY2022 Spending Package (February 2022)
    Cancer Research
    Paid And Caregivers For Paid Leave Letter To President Biden Urging The Reinstatement Of Guaranteed Emergency Paid Leave (February 2022)
    Paid Leave, COVID-19
    Coalition Letter Regarding The Georgia's 1332 Waiver (January 2022)
    Section 1332 Waivers
    Coalition Letter To HHS Re: The Notice Of Benefit And Payment Parameters (NBPP) For 2023 (January 2022)
    Access to Affordable, Comprehensive Care, Affordable Care Act, Medicare, Medicaid, and Private Health Insurance Coverage
    Coalition Letter Urging Limiting The Sale And Availability Of Short Term, Limited Duration Health Insurance (January 2022)
    Medicare, Medicaid, and Private Health Insurance Coverage, Affordable Care Act, Access to Affordable, Comprehensive Care